Ionis Pharmaceuticals Inc
NASDAQ:IONS

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Watchlist
Price: 33.51 USD 0.15% Market Closed
Market Cap: 5.3B USD

Intrinsic Value

IONS's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one IONS stock under the Base Case scenario is 43.87 USD. Compared to the current market price of 33.51 USD, Ionis Pharmaceuticals Inc is Undervalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IONS Intrinsic Value
43.87 USD
Undervaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ionis Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for IONS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Ionis Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ionis Pharmaceuticals Inc

Current Assets 2.4B
Cash & Short-Term Investments 4B
Receivables 39.7m
Other Current Assets -1.6B
Non-Current Assets 394m
PP&E 262.2m
Other Non-Current Assets 131.8m
Efficiency

Free Cash Flow Analysis
Ionis Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ionis Pharmaceuticals Inc

Revenue
717.3m USD
Cost of Revenue
-10.5m USD
Gross Profit
706.7m USD
Operating Expenses
-1.2B USD
Operating Income
-472.4m USD
Other Expenses
14.4m USD
Net Income
-458m USD
Fundamental Scores

IONS Profitability Score
Profitability Due Diligence

Ionis Pharmaceuticals Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional ROIC
ROIC is Increasing
Positive Revenue Growth Forecast
34/100
Profitability
Score

Ionis Pharmaceuticals Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

IONS Solvency Score
Solvency Due Diligence

Ionis Pharmaceuticals Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
High D/E
38/100
Solvency
Score

Ionis Pharmaceuticals Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IONS Price Targets Summary
Ionis Pharmaceuticals Inc

Wall Street analysts forecast IONS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IONS is 59.07 USD with a low forecast of 37.37 USD and a high forecast of 81.9 USD.

Lowest
Price Target
37.37 USD
12% Upside
Average
Price Target
59.07 USD
76% Upside
Highest
Price Target
81.9 USD
144% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for IONS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

IONS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IONS stock?

The intrinsic value of one IONS stock under the Base Case scenario is 43.87 USD.

Is IONS stock undervalued or overvalued?

Compared to the current market price of 33.51 USD, Ionis Pharmaceuticals Inc is Undervalued by 24%.

Back to Top